The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model

OBJECTIVES: To determine whether nalmefene combined with psychosocial support is cost-effective compared with psychosocial support alone for reducing alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels (DRLs) as defined by the WHO, and to evaluate the public he...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Laramée, Philippe, Brodtkorb, Thor-Henrik, Rahhali, Nora, Knight, Chris, Barbosa, Carolina, François, Clément, Toumi, Mondher, Daeppen, Jean-Bernard, Rehm, Jürgen
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2014
Matèries:
Addiction
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4166142/
https://ncbi.nlm.nih.gov/pubmed/25227627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-005376
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars